Journal of dental hygiene science (치위생과학회지)

The Korean Society of Dental Hygiene Science (한국치위생과학회)
권호 표지

Antimicrobial effect of (-)-epigalocatechin on Fusobacterium nucleatum, Prevotella intermedia and Porphyromonas gingivalis

(-)-Epigalocatechin의 Fusobacterium nucleatum, Prevotella intermedia 및 Porphyromonas gingivalis에 대한 항균 효과

  • Park, Jae-Yoon (Department of Biochemistry and Molecular Biology, Medical School, Chosun University) ;
  • Kim, Hwa-Sook (Department of Dental Hygiene, Chunnam Techno College) ;
  • Kook, Joong-Ki (Department of Oral Biochemistry, School of Dentistry, Chosun University)
  • 박재윤 (조선대학교 의과학전문대학원 생화학 분자생물학교실) ;
  • 김화숙 (전남과학대학 치위생과) ;
  • 국중기 (조선대학교 치의학전문대학원 구강생화학교실)
  • Received : 2010.04.06
  • Accepted : 2010.06.18
  • Published : 2010.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to investigate the antimicrobial effect of (-)-epigalocatechin on Fusobacterium nucleatum, Prevotella intermedia, and Porphyromonas gingivalis. To test the antimicrobial effect of (-)-epigalocatechin, the minimum inhibitory concentration (MIC) of against 4 strains of F. nucleatum, 2 strains of P. intermedia, and 2 strains of P. gingivalis was measured by broth dilution method. Time-kill curves were assessed for susceptible bacteria, testing $0{\times}MIC$ (control group), $0.5{\times}MIC$, $1{\times}MIC$, and $2{\times}MIC$ for (-)-epigalocatechin, by counting viable bacteria after 3, 90, 180, 360, 720, 1440 minutes. The MIC of (-)-epigalocatechin was 0.312-0.625, 0.625, and 0.625 mg/ml on the strains of F. nucleatum, P. intermedia, and P. gingivalis, respectively. Time-kill curves demonstrated (-)-epigalocatechin had bactericidal activity on P. intermedia ATCC $25611^T$, P. gingival is ATCC 53978, and F. nucleatum subsp. fusiforme ATCC $51190^T$. The results suggest that (-)-epigalocatechin can be useful in developing the oral hygiene product such as tooth past and gargling solution for the prevention of periodontal diseases.

녹차의 폴리페놀류 중 수용성인 (-)-epigalocatechin을 이용하여 치주질환 원인균에 대한 항세균 작용을 조사한 결과 다음과 같은 결론을 얻었다. 1. (-)-epigalocatechin은 주요한 치주질환 원인균들인 F. nucleatum, P. intermedia 및 P. gingivalis에 대한 최소성장억제농도가 0.625 mg/ml 이하로 항균 작용이 높은 것으로 나타났다. 2. Time-kill 분석법을 실시한 결과 (-)-epigalocatechin은 F. nucleatum, P. intermedia 및 P. gingivalis에 살균작용이 있는 것으로 나타났다. 이상의 결과에서 (-)-epigalocatechin은 치주질환의 예방 및 치주 치료 후 예후를 증진시킬 수 있는 가글린 및 치약 등의 구강위생용품 개발에 이용할 수 있을 것으로 생각된다.

Keywords

References

  1. Gupta S: Chronic infection in the aetiology of atherosclerosisfocus on Chlamydia pneumoniae. Atherosclerosis 143(1): 1-6, 1999. https://doi.org/10.1016/S0021-9150(98)00317-7
  2. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71(10): 1554-1560, 2000. https://doi.org/10.1902/jop.2000.71.10.1554
  3. Darveau RP, Tanner A, Page RC: The microbial challenge in periodontitis. Periodontol 2000 14: 12-32, 1997. https://doi.org/10.1111/j.1600-0757.1997.tb00190.x
  4. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE: Bacterial diversity in human subgingival plaque. J Bacteriol 183(12): 3770-3783, 2001. https://doi.org/10.1128/JB.183.12.3770-3783.2001
  5. Lacroix JM, Walker CB: Detection and prevalence of the tetracycline resistance determinant Tet Q in the microbiota associated with adult periodontitis. Oral Microbiol Immunol 11(4): 282-288, 1996. https://doi.org/10.1111/j.1399-302X.1996.tb00182.x
  6. Olsvik B, Tenover FC: Tetracycline resistance in periodontal pathogens. Clin Infect Dis 16(4): S310-S313, 1993. https://doi.org/10.1093/clinids/16.Supplement_4.S310
  7. Hattori Met, Kusumoto IT, Namba T, Ishigami T, Hara Y: Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) 38(3): 717-720, 1990. https://doi.org/10.1248/cpb.38.717
  8. Lim SH, Seo JS, Yoon YJ, Kim KW, Yoo SY, Kim HS, Kook JK, Lee BR, Cha JH, Park JY: Effect of leaf-extract from Camellia sinensis and seed-extract from Casia tora on viability of mutans streptococci isolated from the interface between orthodontic brackets and tooth surfaces. Korean J Orthodon 33(5): 381-389, 2003.
  9. Hirasawa M, Takada K, Makimura M, Otake S: Improvement of periodontal status by green tea catechin using a local delivery system: A clinical pilot study. J Periodontal Res 37(6): 433-438, 2002. https://doi.org/10.1034/j.1600-0765.2002.01640.x
  10. Murray PR, Jorgensen JH: Quantitative susceptibility test methods in major united states medical center. Antimicrob Agents Chemother 20(1): 66-70, 1981. https://doi.org/10.1128/AAC.20.1.66
  11. Lee ES, Ahn TY, Yoon JJ, Kook JK, Lee RL, Kim DK: Restraint effect on leaf-extract from Camella sinensis and seed-extract from Casia tora against periodontopathogens. J Korean Acad Dent Health 27(4): 569-579, 2003.
  12. Kolenbrander PE, Ganeshkumar N, Cassels FJ, Hughes CV: Coaggregation: specific adherence among human oral plaque bacteria. FASEB J 7(5): 406-413, 1993. https://doi.org/10.1096/fasebj.7.5.8462782
  13. Diaz PI, Zilm PS, Rogers AH: Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments. Microbiol 148(Pt2): 467-472, 2002. https://doi.org/10.1099/00221287-148-2-467
  14. Tew JG, Thomas SS, Ranney RR: Fusobacterium nucleatummediated immunomodulation of the in vitro secondary antibody response to tetanus toxoid and Actinobacillus actinomycetemcomitans. J Periodontal Res 22(6): 506-512, 1987. https://doi.org/10.1111/j.1600-0765.1987.tb02062.x
  15. Dorn BR, Leung KL, Progulske-Fox A: Invasion of human oral epithelial cells by Prevotella intermedia. Infect Immun 66(12): 6054-6057, 1998.
  16. Kim SJ, Ha MS, Choi EY, Choi JI, Choi IS: Prevotella intermedia lipopolysaccharide stimulates release of nitric oxide by inducing expression of inducible nitric oxide synthase. J Periodontal Res 39(6): 424-431, 2004. https://doi.org/10.1111/j.1600-0765.2004.00757.x
  17. Saito K, Takahashi N, Horiuchi H, Yamada T: Effects of glucose on formation of cytotoxic end-products and proteolytic activity of Prevotella intermedia, Prevotella nigrescens and Porphyromonas gingivalis. J Periodontal Res 36(6): 355-360, 2001. https://doi.org/10.1034/j.1600-0765.2001.360602.x
  18. Okamoto M, Maeda N, Kondo K, Leung KP: Hemolytic and hemagglutinating activities of Prevotella intermedia and Prevotella nigrescens. FEMS Microbiol Lett 178(2): 299-304, 1999. https://doi.org/10.1111/j.1574-6968.1999.tb08691.x
  19. Papapanou PN, Neiderud AM, Papadimitriou A, Sandros J, Dahlen G: "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study. J Periodontol 71(6): 885-897, 2000. https://doi.org/10.1902/jop.2000.71.6.885
  20. Kook JK, Sakamoto T, Nishi K, Kim MK, Seong JH, Son YN, Kim DK: Detection of Tannerella forsythia and/or Prevotella intermedia might be useful for microbial predictive markers for the outcome of initial periodontal treatment in Koreans. Microbiol Immunol 49(1): 9-16, 2005. https://doi.org/10.1111/j.1348-0421.2005.tb03634.x
  21. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr: Microbial complexes in subgingival plaque. J Clin Periodontol 25(2): 134-144, 1998. https://doi.org/10.1111/j.1600-051X.1998.tb02419.x
  22. Li X, Kolltveit KM, Tronstad L, Olsen I: Systemic diseases caused by oral infection. Clin Microbiol Rev 13(4):547-558, 2000. https://doi.org/10.1128/CMR.13.4.547-558.2000